Pain is common in children with cerebral palsy. The purpose of this systematic review was to evaluate the evidence regarding assessments and interventions for chronic pain in children aged ≤2 years with or at high risk for cerebral palsy.
Methods:
A comprehensive literature search was performed. Included articles were screened using PRISMA guidelines and quality of evidence was reviewed using best-evidence tools by independent reviewers. Using social media channels, an online survey was conducted to elicit parent preferences.
Results:
Six articles met criteria. Parent perception was an assessment option. Three pharmacologic interventions (gabapentin, medical cannabis, botulinum toxin type A) and 1 nonpharmacologic intervention were identified. Parent survey report parent-comfort and other nonpharmacologic interventions ranked as most preferable.
Conclusion:
A conditional GRADE recommendation was in favor of parent report for pain assessment. Clinical trials are sorely needed because of the lack of evidence for safety and efficacy of pharmacologic interventions.
NovakIHinesMGoldsmithSBarclayR. Clinical prognostic messages from a systematic review on cerebral palsy. Pediatrics. 2012;130(5):e1285–e1312.
2.
DickinsonHOParkinsonKNRavens-SiebererU, et al.Self-reported quality of life of 8–12-year-old children with cerebral palsy: a cross-sectional European study. Lancet. 2007;369(9580):2171–2178.
3.
CuomoAVGamradtSCKimCO, et al.Health-related quality of life outcomes improve after multilevel surgery in ambulatory children with cerebral palsy. J Pediatr Orthopaed. 2007;27(6):653–657.
4.
TsoiWSEZhangLAWangWYTsangKLLoSK. Improving quality of life of children with cerebral palsy: a systematic review of clinical trials. Child Care Health Dev. 2012;38(1):21–31.
5.
McKearnanKAKieckheferGMEngelJMJensenMPLabyakS. Pain in children with cerebral palsy. J Neurosci Nurs. 2004;36(5):252–259.
6.
International Association for the Study of Pain. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd ed. Seattle, WA: International Association for the Study of Pain (IASP) Press; 1994.
TreedeR-DRiefWBarkeA, et al.A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003–1007.
9.
HuntAMastroyannopoulouKGoldmanASeersK. Not knowing—the problem of pain in children with severe neurological impairment. Int J Nurs Stud. 2003;40(2):171–183.
10.
DoralpSBartlettDJ. The prevalence, distribution, and effect of pain among adolescents with cerebral palsy. Pediatr Phys Ther. 2010;22(1):26–33.
11.
ParkinsonKNGibsonLDickinsonHOColverAF. Pain in children with cerebral palsy: a cross-sectional multicentre European study. Acta Paediatr. 2010;99(3):446–451.
12.
RellandLMGehredAMaitreNL. Behavioral and physiological signs for pain assessment in preterm and term neonates during a nociception-specific response: a systematic review. Pediatr Neurol. 2019;90:13–23.
13.
AnandKJSArandaJVBerdeCB, et al.Summary proceedings from the neonatal pain-control group. Pediatrics. 2006;117(suppl 1):S9–S22.
14.
KingsnorthSOravaTProvvidenzaC, et al.Chronic pain assessment tools for cerebral palsy: a systematic review. Pediatrics. 2015;136(4):e947–e960.
15.
OstojicKPagetSPMorrowAM. Management of pain in children and adolescents with cerebral palsy: a systematic review. Dev Med Child Neurol. 2019;61(3):315–321.
16.
SchiaritiVOberlanderTF. Evaluating pain in cerebral palsy: comparing assessment tools using the International Classification of Functioning, Disability and Health. Disabil Rehabil. 2018;41(22):2622–2629.
17.
NovakIMorganCFaheyM, et al.State of the evidence traffic lights 2019: systematic review of interventions for preventing and treating children with cerebral palsy. Curr Neurol Neurosci Rep. 2020;20(2):3.
18.
NovakIMorganCAddeL, et al.Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr. 2017;171(9):897–907.
19.
MaitreNLBurtonVJDuncanAF, et al.Network implementation of guideline for early detection decreases age at cerebral palsy diagnosis. Pediatrics. 2020;145(5):e20192126.
20.
RosenbaumPPanethNLevitonA, et al.A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:8–14.
21.
WhitingPF. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
22.
ViswanathanMBerkmanN. Development of the RTI Item Bank on Risk of Bias and Precision of Observational Studies. Rockville, MD: Agency for Healthcare Research and Quality (US); 2011.
23.
HigginsJPTAltmanDGGotzschePC, et al.The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343: d5928.
24.
Alonso-CoelloPSchünemannHJMobergJ, et al.GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction. BMJ. 2016;353:i2016.
25.
Alonso-CoelloPOxmanADMobergJ, et al.GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines. BMJ. 2016;353:i2089.
HaddenKLvon BaeyerCL. Pain in children with cerebral palsy: common triggers and expressive behaviors. Pain. 2002;99(1):281–288.
28.
JayanathSOngLCMarretMJFauziAA. Parent-reported pain in non-verbal children and adolescents with cerebral palsy. Dev Med Child Neurol. 2016;58(4):395–401.
29.
MisraAKumarSBiswasADasSK. Botulinum toxin type A in subjects with spastic cerebral palsy from Eastern India. J Pediatr Neurol. 2015;08(04):349–357.
30.
HauerJMSolodiukJC. Gabapentin for management of recurrent pain in 22 nonverbal children with severe neurological impairment: a retrospective analysis. J Palliat Med. 2015;18(5):453–456.
31.
LibzonSSchleiderLB-LSabanN, et al.Medical cannabis for pediatric moderate to severe complex motor disorders. J Child Neurol. 2018;33(9):565–571.
32.
ZhaoXChenMDuSLiHLiX. Evaluation of stress and pain in young children with cerebral palsy during early developmental intervention programs. Am J Phys Med Rehabil. 2015;94(3):169–179.
33.
McGrathPJRosmusCCanfieldCCampbellMAHennigarA. Behaviours caregivers use to determine pain in non-verbal, cognitively impaired individuals. Dev Med Child Neurol. 2008;40(5):340–343.
CarlssonAM.Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16(1):87–101.
36.
MerkelSIVoepel-LewisTShayevitzJRMalviyaSV. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs. 1997;233:293–297.
37.
CollocaLLudmanTBouhassiraD, et al.Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002.
38.
YamMLohYTanCKhadijah AdamSAbdul MananNBasirR. General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci. 2018;19(8):2164.
39.
TreedeRDJensenTSCampbellJN, et al.Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2007;70(18):1630–1635.
40.
BlackmanJASvenssonCIMarchandS. Pathophysiology of chronic pain in cerebral palsy: implications for pharmacological treatment and research. Dev Med Child Neurol. 2018;60(9):861–865.
41.
SolodiukJCScott-SutherlandJMeyersM, et al.Validation of the Individualized Numeric Rating Scale (INRS): a pain assessment tool for nonverbal children with intellectual disability. Pain. 2010;150(2):231–236.
42.
StevensBJohnstonCPetryshenPTaddioA. Premature infant pain profile: development and initial validation. Clin J Pain. 1996;12(1):13–22.
43.
LawrenceJAlcockDMcGrathPKayJMacMurraySDulbergC. The development of a tool to assess neonatal pain. Neonatal Netw. 1993;12(6):59–66.
44.
CraigKDHadjistavropoulosHDGrunauRVEWhitfieldMF. A comparison of two measures of facial activity during pain in the newborn child. J Pediatr Psychol. 1994;19(3):305–318.
45.
HummelPPuchalskiMCreechSDWeissMG. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain. J Perinatol. 2007;28(1):55–60.
46.
KrechelSWBildnerJ. CRIES: a new neonatal postoperative pain measurement score. Initial testing of validity and reliability. Pediatr Anaesth. 1995;5(1):53–61.
47.
van DijkMde BoerJBKootHMTibboelDPasschierJDuivenvoordenHJ. The reliability and validity of the COMFORT scale as a postoperative pain instrument in 0 to 3-year-old infants. Pain. 2000;84(2):367–377.
48.
HerrKCoynePJMcCafferyMManworrenRMerkelS. Pain assessment in the patient unable to self-report: position statement with clinical practice recommendations. Pain Manag Nurs. 2011;12(4):230–250.
49.
StevensBMcGrathPGibbinsS, et al.Determining behavioural and physiological responses to pain in infants at risk for neurological impairment. Pain. 2007;127(1):94–102.
50.
HauerJHoutrowAJ. Pain assessment and treatment in children with significant impairment of the central nervous system. Pediatrics. 2017;139(6):e20171002.
51.
ElwynGFroschDThomsonR, et al.Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–1367.
52.
EgunsolaOWylieCEChittyKMBuckleyNA. Systematic review of the efficacy and safety of gabapentin and pregabalin for pain in children and adolescents. Anesth Analg. 2019;128(4):811–819.
53.
WongSSWilensTE. Medical cannabinoids in children and adolescents: a systematic review. Pediatrics. 2017;140(5):e20171818.
54.
VergheseSHannallahRS. Acute pain management in children. J Pain Res. 2010;15(3):105–123.
DowellDHaegerichTMChouR. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624–1645.
63.
EdwardsLDeMeoSHornikCD, et al.Gabapentin use in the neonatal intensive care unit. J Pediatr. 2016;169:310–312.
64.
FriedrichsdorfSJNugentAP. Management of neuropathic pain in children with cancer. Curr Opin Support Palliat Care. 2013;7(2):131–138.
65.
AAP. The assessment and management of acute pain in infants, children, and adolescents. Pediatrics. 2001;108(3):793–797.
66.
MangatAOeiJ-LChenKQuah-SmithISchmölzerG. A review of non-pharmacological treatments for pain management in newborn infants. Children. 2018;5(10):130.
67.
Pillai RiddellRRRacineNMGennisHG, et al.Non-pharmacological management of infant and young child procedural pain. Cochrane Database Syst Rev. 2015;2015(2):CD006275.
68.
GrunauRE. Neonatal pain in very preterm infants: long-term effects on brain, neurodevelopment and pain reactivity. Rambam Maimonides Med J. 2013;4(4):e0025.
69.
KimJGormanJ. The psychobiology of anxiety. Clin Neurosci Res. 2005;4(5-6):335–347.
70.
AnandKJSCarrDB. The neuroanatomy, neurophysiology, and neurochemistry of pain, stress, and analgesia in newborns and children. Pediatr Clin North Am. 1989;36(4):795–822.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
